Annual EBITDA
-$106.86 M
+$9.05 M+7.81%
December 31, 2022
Summary
- As of February 8, 2025, EVLO annual EBITDA is -$106.86 million, with the most recent change of +$9.05 million (+7.81%) on December 31, 2022.
- During the last 3 years, EVLO annual EBITDA has fallen by -$22.27 million (-26.33%).
- EVLO annual EBITDA is now -752.87% below its all-time high of -$12.53 million, reached on December 31, 2016.
Performance
EVLO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$11.05 M
+$8.03 M+42.08%
September 30, 2023
Summary
- As of February 8, 2025, EVLO quarterly EBITDA is -$11.05 million, with the most recent change of +$8.03 million (+42.08%) on September 30, 2023.
- Over the past year, EVLO quarterly EBITDA has increased by +$18.13 million (+62.13%).
- EVLO quarterly EBITDA is now -119.03% below its all-time high of -$5.04 million, reached on March 31, 2017.
Performance
EVLO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$74.40 M
+$18.13 M+19.59%
September 30, 2023
Summary
- As of February 8, 2025, EVLO TTM EBITDA is -$74.40 million, with the most recent change of +$18.13 million (+19.59%) on September 30, 2023.
- Over the past year, EVLO TTM EBITDA has increased by +$38.83 million (+34.29%).
- EVLO TTM EBITDA is now -1374.81% below its all-time high of -$5.04 million, reached on March 31, 2017.
Performance
EVLO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EVLO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.8% | +62.1% | +34.3% |
| 3 y3 years | -26.3% | +43.9% | +11.1% |
| 5 y5 years | -300.3% | +31.5% | +12.0% |
EVLO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7.8% | at high | +62.1% | at high | +36.6% |
| 5 y | 5-year | -26.3% | +7.8% | at high | +65.4% | at high | +36.6% |
| alltime | all time | -752.9% | +7.8% | -119.0% | +65.4% | -1374.8% | +36.6% |
Evelo Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$11.05 M(-42.1%) | -$74.40 M(-19.6%) |
| Jun 2023 | - | -$19.08 M(-19.3%) | -$92.54 M(-9.5%) |
| Mar 2023 | - | -$23.64 M(+14.6%) | -$102.30 M(-4.3%) |
| Dec 2022 | -$106.86 M(-7.8%) | -$20.64 M(-29.3%) | -$106.86 M(-5.6%) |
| Sep 2022 | - | -$29.18 M(+1.2%) | -$113.23 M(-2.4%) |
| Jun 2022 | - | -$28.84 M(+2.3%) | -$116.02 M(-1.1%) |
| Mar 2022 | - | -$28.20 M(+4.4%) | -$117.35 M(+1.2%) |
| Dec 2021 | -$115.92 M(+30.1%) | -$27.01 M(-15.5%) | -$115.92 M(-0.5%) |
| Sep 2021 | - | -$31.96 M(+5.9%) | -$116.49 M(+11.8%) |
| Jun 2021 | - | -$30.18 M(+12.7%) | -$104.20 M(+11.3%) |
| Mar 2021 | - | -$26.77 M(-2.9%) | -$93.59 M(+5.0%) |
| Dec 2020 | -$89.12 M | -$27.57 M(+40.1%) | -$89.12 M(+6.5%) |
| Sep 2020 | - | -$19.68 M(+0.6%) | -$83.72 M(-1.6%) |
| Jun 2020 | - | -$19.57 M(-12.3%) | -$85.07 M(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$22.30 M(+0.6%) | -$86.47 M(+2.2%) |
| Dec 2019 | -$84.59 M(+50.6%) | -$22.17 M(+5.4%) | -$84.59 M(+8.4%) |
| Sep 2019 | - | -$21.04 M(+0.4%) | -$78.06 M(+6.7%) |
| Jun 2019 | - | -$20.96 M(+2.6%) | -$73.16 M(+9.6%) |
| Mar 2019 | - | -$20.43 M(+30.7%) | -$66.76 M(+18.9%) |
| Dec 2018 | -$56.17 M(+110.4%) | -$15.63 M(-3.1%) | -$56.17 M(+16.2%) |
| Sep 2018 | - | -$16.13 M(+10.8%) | -$48.36 M(+20.8%) |
| Jun 2018 | - | -$14.56 M(+48.0%) | -$40.02 M(+27.1%) |
| Mar 2018 | - | -$9.84 M(+25.8%) | -$31.49 M(+18.0%) |
| Dec 2017 | -$26.70 M(+113.1%) | -$7.82 M(+0.3%) | -$26.70 M(+41.4%) |
| Sep 2017 | - | -$7.80 M(+29.3%) | -$18.88 M(+70.4%) |
| Jun 2017 | - | -$6.03 M(+19.5%) | -$11.08 M(+119.5%) |
| Mar 2017 | - | -$5.04 M | -$5.04 M |
| Dec 2016 | -$12.53 M | - | - |
FAQ
- What is Evelo Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Evelo Biosciences?
- What is Evelo Biosciences annual EBITDA year-on-year change?
- What is Evelo Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Evelo Biosciences?
- What is Evelo Biosciences quarterly EBITDA year-on-year change?
- What is Evelo Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Evelo Biosciences?
- What is Evelo Biosciences TTM EBITDA year-on-year change?
What is Evelo Biosciences annual EBITDA?
The current annual EBITDA of EVLO is -$106.86 M
What is the all time high annual EBITDA for Evelo Biosciences?
Evelo Biosciences all-time high annual EBITDA is -$12.53 M
What is Evelo Biosciences annual EBITDA year-on-year change?
Over the past year, EVLO annual EBITDA has changed by +$9.05 M (+7.81%)
What is Evelo Biosciences quarterly EBITDA?
The current quarterly EBITDA of EVLO is -$11.05 M
What is the all time high quarterly EBITDA for Evelo Biosciences?
Evelo Biosciences all-time high quarterly EBITDA is -$5.04 M
What is Evelo Biosciences quarterly EBITDA year-on-year change?
Over the past year, EVLO quarterly EBITDA has changed by +$18.13 M (+62.13%)
What is Evelo Biosciences TTM EBITDA?
The current TTM EBITDA of EVLO is -$74.40 M
What is the all time high TTM EBITDA for Evelo Biosciences?
Evelo Biosciences all-time high TTM EBITDA is -$5.04 M
What is Evelo Biosciences TTM EBITDA year-on-year change?
Over the past year, EVLO TTM EBITDA has changed by +$38.83 M (+34.29%)